213 related articles for article (PubMed ID: 17035711)
1. Rate of decline of GFR and progression of vascular disease in type 2 diabetic patients with diabetic or vascular nephropathy during the last three years before starting dialysis therapy.
Biesenbach G; Schmekal B; Pieringer H; Janko O
Kidney Blood Press Res; 2006; 29(5):267-72. PubMed ID: 17035711
[TBL] [Abstract][Full Text] [Related]
2. High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy.
Biesenbach G; Zazgornik J
Ren Fail; 1994; 16(2):263-72. PubMed ID: 8041965
[TBL] [Abstract][Full Text] [Related]
3. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
[TBL] [Abstract][Full Text] [Related]
4. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.
Nakano S; Fukuda M; Hotta F; Ito T; Ishii T; Kitazawa M; Nishizawa M; Kigoshi T; Uchida K
Diabetes; 1998 Sep; 47(9):1501-6. PubMed ID: 9726241
[TBL] [Abstract][Full Text] [Related]
5. Influence of smoking on the survival rate of diabetic patients requiring hemodialysis.
Biesenbach G; Zazgornik J
Diabetes Care; 1996 Jun; 19(6):625-8. PubMed ID: 8725862
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis in patients older than 65 years with end-stage renal failure--comparison of outcome in patients with and without diabetes.
Pieringer H; Biesenbach G
Z Gerontol Geriatr; 2008 Apr; 41(2):139-45. PubMed ID: 18327697
[TBL] [Abstract][Full Text] [Related]
7. Clinical versus histological diagnosis of diabetic nephropathy--is renal biopsy required in type 2 diabetic patients with renal disease?
Biesenbach G; Bodlaj G; Pieringer H; Sedlak M
QJM; 2011 Sep; 104(9):771-4. PubMed ID: 21504987
[TBL] [Abstract][Full Text] [Related]
8. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
Mottl AK; Buse JB; Ismail-Beigi F; Sigal RJ; Pedley CF; Papademetriou V; Simmons DL; Katz L; Mychaleckyj JC; Craven TE
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1693-1702. PubMed ID: 30361335
[TBL] [Abstract][Full Text] [Related]
10. Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.
Christensen PK; Rossing P; Nielsen FS; Parving HH
Diabet Med; 1999 May; 16(5):388-94. PubMed ID: 10342338
[TBL] [Abstract][Full Text] [Related]
11. Progression of nephropathy in type 2 diabetic patients.
Rossing K; Christensen PK; Hovind P; Tarnow L; Rossing P; Parving HH
Kidney Int; 2004 Oct; 66(4):1596-605. PubMed ID: 15458456
[TBL] [Abstract][Full Text] [Related]
12. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.
Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y
Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017
[TBL] [Abstract][Full Text] [Related]
13. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
15. Progression of diabetic nephropathy.
Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
Kidney Int; 2001 Feb; 59(2):702-9. PubMed ID: 11168952
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the progression of diabetic nephropathy and its complications: a single-center experience in Saudi Arabia.
Alwakeel JS; Isnani AC; Alsuwaida A; Alharbi A; Shaffi SA; Almohaya S; Al Ghonaim M
Ann Saudi Med; 2011; 31(3):236-42. PubMed ID: 21623051
[TBL] [Abstract][Full Text] [Related]
17. Abysmal prognosis of patients with type 2 diabetes entering dialysis.
Chantrel F; Enache I; Bouiller M; Kolb I; Kunz K; Petitjean P; Moulin B; Hannedouche T
Nephrol Dial Transplant; 1999 Jan; 14(1):129-36. PubMed ID: 10052492
[TBL] [Abstract][Full Text] [Related]
18. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus.
Biesenbach G; Janko O; Zazgornik J
Nephrol Dial Transplant; 1994; 9(8):1097-102. PubMed ID: 7800207
[TBL] [Abstract][Full Text] [Related]
19. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.
Minutolo R; Sasso FC; Chiodini P; Cianciaruso B; Carbonara O; Zamboli P; Tirino G; Pota A; Torella R; Conte G; De Nicola L
J Hypertens; 2006 Aug; 24(8):1655-61. PubMed ID: 16877970
[TBL] [Abstract][Full Text] [Related]
20. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
